Cargando…

Cerebrospinal fluid biomarkers in patients with plasma HIV RNA below 20 copies/mL

INTRODUCTION: Low level HIV-1 CSF replication (CsfLLV) is often found even in patients with controlled plasma viraemia. The clinical consequences of such finding are uncertain; however, both symptomatic neurological disturbances and neurocognitive disorders may arise in the context of CSF-escape. Tw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calcagno, Andrea, Atzori, Cristiana, Romito, Alessandra, Ecclesia, Sara, Imperiale, Daniele, Audagnotto, Sabrina, Chiara Alberione, Maria, Trentalange, Alice, Di Perri, Giovanni, Bonora, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P187
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225354/ https://www.ncbi.nlm.nih.gov/pubmed/25397465 http://dx.doi.org/10.7448/IAS.17.4.19719

Ejemplares similares

Santé mentale du personnel hospitalier belge durant la première vague de COVID-19
por: Windal, Maxime, et al.
Publicado: (2023)

Food intake assessment and anthropometric characterisation of teenage gymnasts
por: Holanda, Marcela, et al.
Publicado: (2021)

Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting
por: Gianotti, Nicola, et al.
Publicado: (2014)

Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
por: Stroffolini, Giacomo, et al.
Publicado: (2021)

Patterns of Cerebrospinal Fluid Alzheimer’s Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition
por: Trunfio, Mattia, et al.
Publicado: (2022)

Four-drugs regimen containing raltegravir is highly effective in HIV patients starting therapy with >500,000 copies/mL viral load
por: Sterrantino, Gaetana, et al.
Publicado: (2014)

Blood–Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers
por: Caligaris, Giulia, et al.
Publicado: (2021)

Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mL
por: Dentone, Chiara, et al.
Publicado: (2014)

Viro-immunological characterization of naïve patients with high cerebrospinal fluid (CSF) HIV RNA
por: Iannuzzi, Francesca, et al.
Publicado: (2014)

Cerebrospinal-fluid exposure of efavirenz and its major metabolites when dosed at 400 and 600 mg once daily; a randomized controlled trial
por: Winston, Alan, et al.
Publicado: (2014)

The PROTEA trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV-1 RNA below 50 copies/mL
por: Antinori, Andrea, et al.
Publicado: (2014)

Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice
por: Costarelli, Silvia, et al.
Publicado: (2014)

An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy
por: Calcagno, Andrea, et al.
Publicado: (2021)

Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ≥50 years
por: Gazzard, Brian, et al.
Publicado: (2014)

Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants
por: Cusato, Jessica, et al.
Publicado: (2023)

Alarming increase in tuberculosis and hepatitis C virus (HCV) among HIV infected intravenous drug users
por: Oprea, Cristiana, et al.
Publicado: (2014)

A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load
por: Calcagno, A, et al.
Publicado: (2010)

Assurer le contrôle qualité d'un essai clinique pendant la pandémie de COVID-19 : l'expérience de l'étude Inserm C20-15 DisCoVeRy en France
por: Fougerou-leurent, C., et al.
Publicado: (2022)

CellML 2.0
por: Clerx, Michael, et al.
Publicado: (2020)

Markers of CNS Injury in Adults Living With HIV With CSF HIV Not Detected vs Detected <20 Copies/mL
por: Farhadian, Shelli F, et al.
Publicado: (2019)

Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases
por: Trunfio, Mattia, et al.
Publicado: (2021)

S129: ADOPTIVELY INFUSED MEMORY-LIKE (ML) NATURAL KILLER (NK) CELLS ELICIT ADAPTIVE IMMUNE RESPONSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
por: Rutella, Sergio, et al.
Publicado: (2023)

Blackwater Fever in Children, Burundi
por: Gobbi, Federico, et al.
Publicado: (2005)

Immunité cellulaire et humorale anti-SARS-CoV-2 chez les patients SEP traités par anti-CD20
por: Nicolas, Philippe, et al.
Publicado: (2023)

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
por: Trunfio, Mattia, et al.
Publicado: (2020)

Anti-CD20 et sévérité de la COVID-19 chez les patients SEP : un impact différent chez les SEP rémittents et progressifs, dans la cohorte COVISEP
por: Januel, Édouard, et al.
Publicado: (2023)

Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients
por: Mengoli, Carlo, et al.
Publicado: (2014)

Comparison of HIV-1 drug resistance profiles generated from novel software applications for routine patient care
por: Gonzalez, Dimitri, et al.
Publicado: (2014)

Switching from an EFV-based STR to a RPV-based STR is effective, safe and improves HIV patients health status
por: Maggiolo, Franco, et al.
Publicado: (2014)

Pregnancy outcomes in women growing up with perinatally acquired HIV in the United Kingdom and Ireland
por: Byrne, Laura, et al.
Publicado: (2014)

Who gets single tablet regimens (STR), and why?
por: Tarrier, Laura, et al.
Publicado: (2014)

Lamivudine monotherapy as a safe option for HIV-infected paediatric clients with adherence challenges: new evidence from a large South African cohort
por: Linder, Verena, et al.
Publicado: (2014)

Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study
por: Fowler, Nikola, et al.
Publicado: (2014)

APRI and FIB-4 scores are not associated with neurocognitive impairment in HIV-infected persons
por: Libertone, Raffaella, et al.
Publicado: (2014)

Two years of Truvada for pre-exposure prophylaxis utilization in the US
por: Flash, Charlene, et al.
Publicado: (2014)

Longitudinal comparison of HIV-1 plasma viral load and cellular proviral load
por: Schweitzer, Finja, et al.
Publicado: (2014)

Viral escape in the CNS with multidrug-resistant HIV-1
por: Béguelin, Charles, et al.
Publicado: (2014)

Research on demands and accessibility of health services for AIDS long-surviving patients with AIDS-nonrelated diseases: a survey in central China
por: He, Na, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lqsrhoc49e8ns2071dg4e5vt4o